Beckman Daniella

Chief Financial Officer at TNGX

Sold, on record
$199k
Dollars the filings state
Form 4 sales
3
Latest Feb 3, 2026
Form 144 notices
0
Proposed sales
Companies
1
Filed as an executive or holder

Companies

  • TNGXTango Therapeutics, Inc.Chief Financial Officer

Sales by reason

0
Routine
0
Plan not stated
1
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 4 sale TNGXNo plan
    Feb 7 2024

    Sold 3,725 shares at $12.59 ($47k)

    Beckman Daniella, Chief Financial Officer

    No 10b5-1 planSold 2.7% of holdings ($1.7M position)132,397 shares leftFirst sale on recordFiling

  2. 2 Form 4 sale TNGXNo plan
    Feb 5 +364 days

    Sold 8,232 shares at $3.07 ($25k)

    Beckman Daniella, Chief Financial Officer

    No 10b5-1 planSold 5.2% of holdings ($487k position)150,284 shares leftFiling

  3. 3 Form 4 sale TNGXNo plan
    Feb 3 +363 days

    Sold 10,317 shares at $12.27 ($127k)

    Beckman Daniella, Chief Financial Officer

    No 10b5-1 planSold 5.3% of holdings ($2.4M position)184,297 shares leftFiling

Every transaction

Loading transactions…

Sales and notices (3)

Form 144 notices and Form 4 sales by Beckman Daniella
Source
Feb 3, 2026TNGXChief Financial OfficerForm 4 sale10,317$127k5.3%No planSEC
Feb 5, 2025TNGXChief Financial OfficerForm 4 sale8,232$25k5.2%No planSEC
Feb 7, 2024TNGXChief Financial OfficerForm 4 sale3,725$47k2.7%No planSEC